Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: Information has been received from SPMSD (manufacturer control no. DK-1577272925-2016009200) on 15-SEP-2016. Case received from a physician via Health Authority on 12-Sep-2016 under reference no DK-DKMA-WBS-0004422 / DK-DKMA-ADR 23638549. A 12-year-old female adolescent patient received GARDASIL (batch number Not available, Dose 1) via intramuscular route on 18-Sep-2012, GARDASIL (batch number Not available, Dose 2) via intramuscular route on 21-Nov-2012, GARDASIL, (batch number Not available, Dose 3) via intramuscular route on 15-May-2013. The patient experienced Headache tension, Fatigue, Attention impaired and Coxitis on an unknown date. Description: The patient has a number of diffuse symptoms. The temporal relation to GARDASIL vaccination is uncertain. Before and prior to the symptoms, there were significant psychosocial issues which more likely explains the events. Other Vaccines: No. Other Medicines: No. The patient''s outcome was reported as Not Recovered/Not Resolved for Headache tension and Attention impaired. The patient''s outcome was reported as Recovering/Resolving for Fatigue and Coxitis.
Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166